Computational Identification of Potent Multitarget Natural Ligands for Alzheimer’s Disease Therapeutics
Nadia Sharif, Ayesha Bibi, Rakhshinda Sadiq, Iffat Ullah, Abdul Rauf, Muhammad Tayyab Arshad, Shahid Bashir, Hafsa Zamir, Sawaira Gull, Taqwa Anwar, Emmanuel Laryea · 2025
Read Computational Identification of Potent Multitarget Natural Ligands for Alzheimer’s Disease Therapeutics by Nadia Sharif, Ayesha Bibi, Rakhshinda Sadiq, Iffat Ullah, Abdul Rauf, Muhammad Tayyab Arshad, Shahid Bashir, Hafsa Zamir, Sawaira Gull, Taqwa Anwar, Emmanuel Laryea (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12782343.txt.
Description
Nadia Sharif and co-authors screened in 2025 natural compounds by computer for multi-target drugs against Alzheimer's disease. The disease involves several proteins at once, so a single compound that binds many of them is attractive. Their search targeted four proteins tied to the disease, a combination not tried together before in docking studies.
Fifteen natural compounds and three standard drugs were checked for drug-like traits, body handling, and toxicity risk, then docked against each target. One compound from ginkgo bound all targets strongly, including a key spot on the tau protein. Plant compounds from ginseng and other sources also scored well. Some candidates carried liver toxicity warnings that would need work.
Catalog record
| CREATOR | Nadia Sharif, Ayesha Bibi, Rakhshinda Sadiq, Iffat Ullah, Abdul Rauf, Muhammad Tayyab Arshad, Shahid Bashir, Hafsa Zamir, Sawaira Gull, Taqwa Anwar, Emmanuel Laryea |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |